Insider · CIK 0001745853

GRIMALDI CLAUDIA

Reports to the SEC for 1 company · POTOMAC, MD

sec.gov

Transactions

Companies

Filings

CIK

0001745853

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-25	IGCIGC Pharma, Inc.G Gift	Director, PFO	GGift	−150K sh	—	—	3,271,092
2026-06-30	IGCIGC Pharma, Inc.A Award	Director, PFO	AAward	+2.05M sh	$0.27	+$553K	3,421,092
2026-04-01	IGCIGC Pharma, Inc.M Exercise/Conversion	Director, PFO	MExercise/Conversion	+138K sh	$0.26	+$36K	1,372,714
2026-04-01	IGCIGC Pharma, Inc.M Exercise/Conversion	Director, PFO	MExercise/Conversion	+100K sh	—	—	1,234,252
2026-04-01	IGCIGC Pharma, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, PFO	MExercise/Conversion	−100K sh	—	—	0
2026-04-01	IGCIGC Pharma, Inc. · OptionsM Exercise/Conversion	Director, PFO	MExercise/Conversion	−138K sh	—	—	221,538
2025-10-17	IGCIGC Pharma, Inc. · OptionsA Award	Director, PFO	AAward	+500K sh	—	—	500,000
2025-10-17	IGCIGC Pharma, Inc.G Gift	Director, PFO	GGift	−50K sh	—	—	1,134,252
2025-10-17	IGCIGC Pharma, Inc. · OptionsA Award	Director, PFO	AAward	+1M sh	—	—	1,000,000
2025-03-31	IGCIGC Pharma, Inc.M Exercise/Conversion	Director, PFO	MExercise/Conversion	+58.3K sh	—	—	1,084,252
2025-03-31	IGCIGC Pharma, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, PFO	MExercise/Conversion	−100K sh	—	—	100,000
2025-03-31	IGCIGC Pharma, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, PFO	MExercise/Conversion	−58.3K sh	—	—	0
2025-03-31	IGCIGC Pharma, Inc.M Exercise/Conversion	Director, PFO	MExercise/Conversion	+100K sh	—	—	1,184,252
2024-03-13	IGCIGC Pharma, Inc. · OptionsA Award	Director, PFO	AAward	+550K sh	—	—	550,000
2024-03-13	IGCIGC Pharma, Inc. · OptionsA Award	Director, PFO	AAward	+360K sh	—	—	360,000
2024-03-13	IGCIGC Pharma, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, PFO	MExercise/Conversion	−100K sh	—	—	200,000
2024-03-13	IGCIGC Pharma, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, PFO	MExercise/Conversion	−58.3K sh	—	—	58,332
2024-03-13	IGCIGC Pharma, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, PFO	MExercise/Conversion	−83.3K sh	—	—	0
2024-03-13	IGCIGC Pharma, Inc.M Exercise/Conversion	Director, PFO	MExercise/Conversion	+95K sh	—	—	1,037,154
2024-03-13	IGCIGC Pharma, Inc.M Exercise/Conversion	Director, PFO	MExercise/Conversion	+100K sh	—	—	942,154
2024-03-13	IGCIGC Pharma, Inc.M Exercise/Conversion	Director, PFO	MExercise/Conversion	+58.3K sh	—	—	842,154
2024-03-13	IGCIGC Pharma, Inc.M Exercise/Conversion	Director, PFO	MExercise/Conversion	+83.3K sh	—	—	783,821
2024-03-13	IGCIGC Pharma, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, PFO	MExercise/Conversion	−95K sh	—	—	285,000
2023-06-20	IGCIGC Pharma, Inc. · Restricted Stock UnitsA Award	Director, PFO	AAward	+380K sh	—	—	380,000
2023-06-20	IGCIGC Pharma, Inc. · Restricted Stock UnitsA Award	Director, PFO	AAward	+300K sh	—	—	300,000
2023-03-31	IGCIGC Pharma, Inc.M Exercise/Conversion	Director, PFO	MExercise/Conversion	+58.3K sh	—	—	700,488
2023-03-31	IGCIGC Pharma, Inc.M Exercise/Conversion	Director, PFO	MExercise/Conversion	+83.3K sh	—	—	642,154
2023-03-31	IGCIGC Pharma, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, PFO	MExercise/Conversion	−58.3K sh	—	—	116,666
2023-03-31	IGCIGC Pharma, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, PFO	MExercise/Conversion	−83.3K sh	—	—	83,833
2022-06-01	IGCIGC Pharma, Inc.M Exercise/Conversion	Director, PFO	MExercise/Conversion	+9,375 sh	—	—	558,821
2022-06-01	IGCIGC Pharma, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, PFO	MExercise/Conversion	−9,375 sh	—	—	279,166
2022-05-31	IGCIGC Pharma, Inc.M Exercise/Conversion	Director, PFO	MExercise/Conversion	+28.1K sh	—	—	549,446
2022-05-31	IGCIGC Pharma, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, PFO	MExercise/Conversion	−28.1K sh	—	—	288,541
2022-05-25	IGCIGC Pharma, Inc. · Restricted Stock UnitsA Award	Director, PFO	AAward	+175K sh	—	—	175,000
2022-03-21	IGCIGC Pharma, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, PFO	MExercise/Conversion	−83.3K sh	—	—	316,666
2022-03-21	IGCIGC Pharma, Inc.M Exercise/Conversion	Director, PFO	MExercise/Conversion	+83.3K sh	—	—	521,321
2021-12-20	IGCIGC Pharma, Inc.A Award	Director, PFO	AAward	+250K sh	—	—	437,987
2021-12-20	IGCIGC Pharma, Inc. · Restricted Stock UnitsA Award	Director, PFO	AAward	+150K sh	—	—	400,000
2021-12-20	IGCIGC Pharma, Inc. · Restricted Stock UnitsA Award	Director, PFO	AAward	+250K sh	—	—	250,000
2021-05-13	IGCIGC Pharma, Inc.G Gift	Director, PFO	GGift	−500K sh	—	—	437,987
2021-05-13	IGCIGC Pharma, Inc.A Award	Director, PFO	AAward	+250K sh	—	—	787,987
2021-05-13	IGCIGC Pharma, Inc.G Gift	Director, PFO	GGift	−500K sh	—	—	537,987
2021-05-13	IGCIGC Pharma, Inc.A Award	Director, PFO	AAward	+250K sh	—	—	687,987
2020-11-03	IGCIGC Pharma, Inc.G Gift	Director, PFO	GGift	−100K sh	—	—	937,987
2020-11-03	IGCIGC Pharma, Inc.G Gift	Director, PFO	GGift	−100K sh	—	—	1,037,987
2020-03-19	IGCIGC Pharma, Inc.A Award	Director, PFO	AAward	+200K sh	—	—	1,037,987
2019-11-22	IGCIGC Pharma, Inc.G Gift	Director, PFO	GGift	−15K sh	—	—	837,987
2019-06-11	IGCIGC Pharma, Inc.A Award	Director, PFO	AAward	+300K sh	—	—	852,987
2018-08-30	IGCIGC Pharma, Inc.S Sale	Director, PFO	SSale	−116K sh	$2.00	−$232K	552,987
2018-08-29	IGCIGC Pharma, Inc.A Award	Director, PFO	AAward	+75K sh	—	—	669,007

Recent filings

Accepted (ET)
Sep 294
GRIMALDI CLAUDIA0001185185-26-004408
SEC(opens sec.gov)
Jul 14
GRIMALDI CLAUDIA0001185185-26-002764
SEC(opens sec.gov)
Apr 64
GRIMALDI CLAUDIA0001185185-26-001283
SEC(opens sec.gov)
Oct 214
GRIMALDI CLAUDIA0001185185-25-001504
SEC(opens sec.gov)
May 155
GRIMALDI CLAUDIA0001185185-25-000493
SEC(opens sec.gov)
Mar 154
GRIMALDI CLAUDIA0001185185-24-000264
SEC(opens sec.gov)

Companies

IGC Pharma, Inc.Director, PFOIGC

Address

10224 FALLS ROAD

POTOMAC, MD, 20854